Breast Cancer Risk after Diagnostic Gene Sequencing (BRIDGES)

Livrables

A catalogue of (non-)spliceogenic variants

A catalogue of spliceogenic and non-spliceogenic variants (consensus site variants, nonsense variants, and indel variants) causing deleterious or non-deleterious splicing alterations in the 11 BC-HR genes.

Risk model validation

Report on model validation in KARMA and GC-HBOC. The final BOADICEA model will be evaluated in two prospective cohort studies (KARMA and GC-HBOC). Sequencing data from the BRIDGES panel, together with data on the SNP polygenic risk score (PRS), lifestyle risk factors and breast density, will be obtained from ~1,500 cases and 1,500 matched controls. The model will be evaluated for calibration and discrimination, and compared with the existing BOADICEA model.

Results from RIgORouS analysis

Report on the analysis results of the RIgORouS pipeline for 250 VUS.

Risk estimates Panel 1

Report on risk estimates for variants in genes on Panel 1 The principal strategy will be to estimate risks for categories of variants defined by insilico and functional characterization We will estimate hazard ratios using a maximum likelihood approach The advantage of this approach is that the same method can be used for the populationbased and clinicbased studies

Report on BOADICEA-PLUS

Report on BOADICEA-PLUS, including risk estimates for genes on BRIDGES Panel. The BOADICEA online interface will be upgraded to incorporate data on variants in BC genes, in addition to common variants, family history, lifestyle risk factors and breast density, thus providing individualised absolute risk estimates for breast cancer by subtype, and, where possible, other cancers. An interface to allow sequence variant files to be read automatically will be developed. We will provide a direct link to the Alamut database, so that users can query data on the variant classification.

A template for psychological intervention

A report presenting a template for psychological intervention, and a structured psychological evaluation and intervention concept. This will entail a questionnaire addressing the specific psychosocial difficulties and needs that counselees attending cancer genetics clinics in France, Germany and Spain may present during the course of counselling. A specific scoring procedure and interpretation was provided by the PAHC validation study. The intervention concept is to screen and monitor counselees’ needs for additional intervention, and to improve the care provided in genetics clinics according to evolving knowledge, technology and practice.

Predictive value of functional analyses

Report on predictive value of functional analyses in reanalysis of Panel 1 dataset Once functional analysis and detailed insilicostructural predictions have been completed WP4 we will then rederive risk estimates for those Panel 1 genes based an updated classification scheme that incorporates functional predictions BRIDGESv2 We will evaluate for each gene using regression analyses whether functional prediction is associated with risk after adjustment for the insilico prediction Since the genes evaluated in WP4 are all involved in DNA repair and are being subject to similar functional assays it may be feasible to perform global analyses across genes

Survey results of BOADICEA-PLUS

A comprehensive description of survey results of BOADICEA-PLUS users. Online surveys among genetic counselors on the use of BOADICEA-PLUS, by analyzing the number and type of website connections and by using online questionnaires. We will use two validated instruments for our evaluation: the System Usability Scale (SUS) and the Center for Healthcare Evaluation Provider Satisfaction Questionnaire (CHCE-PSQ). These instruments have been recently used to evaluate the uptake of an online tool to guide BRCA1/2 mutation carrier women in their prophylactic surgery decisions.

Combined analysis of exome and gene panel sequencing

A report of the analysis of the data that were used to select the genes for panel 2 (specifically from the combined analysis of COMPLEXO and PERSPECTIVE).

Position report on best practice and recommendations for genetic counselling

Position report on best practice and recommendations for genetic counseling based on the use of BOADICEAPLUS D55 and Task 55

Final Meeting

We will organise a final meeting together with BCAST which will be open to a much wider community than just the consortium members in order to provide a much broader dissemination of project results

Survey results of BOADICEA

A comprehensive description of survey results of current BOADICEA users. Online surveys among genetic counselors on the use of the present BOADICEA tool, by analyzing the number and type of BOADICEA website connections and by using online questionnaires. We will use two validated instruments for our evaluation: the System Usability Scale (SUS) and the Center for Healthcare Evaluation Provider Satisfaction Questionnaire (CHCE-PSQ). These instruments have been recently used to evaluate the uptake of an online tool to guide BRCA1/2 mutation carrier women in their prophylactic surgery decisions.

A high-throughput functional analysis system (RIgORouS)

A high-throughput functional analysis system (RIgORouS) for 11 BC-HR genes. The final analysis pipeline (RIgORouS) exploits three read-out systems (Figure 3.1d): 1. RAD51 foci analysis 2. Analysis of homologous recombination 3. Analysis of sensitivity to PARPi

Validated instruments for the identification of patients with psychological distress

Validated instruments for the identification of patients with psychological distress and structured intervention concept. We will assess the Psychosocial Aspects of Hereditary Cancer (PAHC), and the Distress Thermometer, in women undergoing genetic testing for breast cancer risk in Cancer Genetic Clinics from different EU countries. The PAHC questionnaire is dedicated to cancer genetic clinics, and has recently been validated in Dutch cancer clinics; it will be translated into English, German, French, and Spanish. Moreover, the PAHC will be modified and validated in the same cohort for the evaluation of psychosocial distress in post-test counselling concerning the uptake of preventive measures (postPAHC). A cross-cultural validity of both versions will be performed through the first patients included in the prospective observational study. At least 312 patients will be accrued in the institutes of P7 and P8, according to published recommendations.

A panel of validated minigene-based splicing assays

A panel of validated minigene-based splicing assays for 11 BC-HR genes. We will synthesize minigenes covering all exons for the selected BC-HR genes. Constructs will be transfected into human epithelial (breast cancer) cell lines. RNA will be extracted and minigene transcripts will be amplified using plasmid-specific primers and analysed by CEP and Sanger sequencing.

A catalogue of naturally occurring alternative splicing

A catalogue of naturally occurring alternative splicing events in lymphocytes and epithelial breast tissue in 11 BC-HR genes. We will use GENCODE annotations (retrieved from Ensemble) to predict alternative splicing events occurring in the 11 BC-HR genes. This information will be used to design a set of overlapping cDNA amplicons covering the full-length reference transcript of each gene. Subsequently, RNA from lymphocytes (healthy blood donors) and from normal breast tissue (either commercially available or from cosmetic surgery) will be used for analysis of RT-PCR amplicons by capillary electrophoresis (CEP) and direct sequencing by Sanger. This will yield a catalogue of alternative splicing for each of the BC-HR genes, as well as tissue-specific differences therein.

Patient decision aid for counselees

A patient decision aid PDA will be developed in a multidisciplinary team including patients We will first assess the content of a PDA for the uptake of preventive measures in women with moderate disease risk and define topic content target audience distribution strategy and objectives of the information Then we will establish content based on a literature review user expectations and other sources of information and develop the PDA based on the methods of evidencebased medicine and established quality criteria DISCERN IPDAS and others The PDA will be tested for readability understanding and presentation ie of risks and an option grid wwwoptiongridorg will be designed to help counselors and counselees talk about how best to handle disease risk with a strong focus on evidencebased preventive measures

An e-Learning tool for genetic counsellors

An elearning tool for counselors in the posttest setting including a video tutorial and a manual will be developed in three steps 1 a systematic literature review will be conducted to identify evidencebased counseling programs and routinely used information formats for posttest counseling for health care professionals 2 results from the questionnaire for BOADICEA users will be considered in order to grip users needs 3 validation of the prototype in focus group discussions with genetic counsellors and patients at risk for hereditary breast and ovarian cancer syndrome We plan on 6 to 10 focus groups based on selective sampling Each group will comprise between 6 to 10 participants Cancer family clinics from different countries will be invited to participate The number of focus groups will depend on the achievement of a theoretical saturation of 80 An interview guide will be developed to advice focus group interviews Interviews will be taped transcribed verbatim and evaluated using the software MAXQDA

Dissemination of variants

Dissemination of sequence variants in public domain through locusspecific Leiden Opensource Variant databases LOVD All variants detected in the genes analyzed in the 60000 individuals will be deposited in the public domain through genespecific LOVD databases

Upgraded Alamut Tool

Online Alamut tool upgraded with risk estimates from BRIDGES The results from risk analyses D31 D33 will be used to provide summary evaluations of the evidence for each geneclass being associated with risk and the relative risk of breast cancer and other cancers associated with each variant These results will be made available through the Alamut genome browser

Project Website

Launch of project website with information on project related matters for the general public and a passwordprotected part for members of the consortium

Publications

CanRisk Tool—A Web Interface for the Prediction of Breast and Ovarian Cancer Risk and the Likelihood of Carrying Genetic Pathogenic Variants

Auteurs: Tim Carver, Simon Hartley, Andrew Lee, Alex P. Cunningham, Stephanie Archer, Chantal Babb de Villiers, Jonathan Roberts, Rod Ruston, Fiona M. Walter, Marc Tischkowitz, Douglas F. Easton, Antonis C. Antoniou
Publié dans: Cancer Epidemiology Biomarkers & Prevention, Numéro 30/3, 2021, Page(s) 469-473, ISSN 1055-9965
Éditeur: American Association for Cancer Research
DOI: 10.1158/1055-9965.epi-20-1319

Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk

Auteurs: Pooja Middha Kapoor, Nasim Mavaddat, Parichoy Pal Choudhury, Amber N Wilcox, Sara Lindström, Sabine Behrens, Kyriaki Michailidou, Joe Dennis, Manjeet K Bolla, Qin Wang, Audrey Jung, Zomoroda Abu-Ful, Thomas Ahearn, Irene L Andrulis, Hoda Anton-Culver, Volker Arndt, Kristan J Aronson, Paul L Auer, Laura E Beane Freeman, Heiko Becher, Matthias W Beckmann, Alicia Beeghly-Fadiel, Javier Benitez, Lesl
Publié dans: JNCI: Journal of the National Cancer Institute, Numéro 113/3, 2020, Page(s) 329-337, ISSN 0027-8874
Éditeur: Oxford University Press
DOI: 10.1093/jnci/djaa056

European polygenic risk score for prediction of breast cancer shows similar performance in Asian women

Auteurs: Weang-Kee Ho, Min-Min Tan, Nasim Mavaddat, Mei-Chee Tai, Shivaani Mariapun, Jingmei Li, Peh-Joo Ho, Joe Dennis, Jonathan P. Tyrer, Manjeet K. Bolla, Kyriaki Michailidou, Qin Wang, Daehee Kang, Ji-Yeob Choi, Suniza Jamaris, Xiao-Ou Shu, Sook-Yee Yoon, Sue K. Park, Sung-Won Kim, Chen-Yang Shen, Jyh-Cherng Yu, Ern Yu Tan, Patrick Mun Yew Chan, Kenneth Muir, Artitaya Lophatananon, Anna H. Wu, Daniel O
Publié dans: Nature Communications, Numéro 11/1, 2020, Page(s) 3833, ISSN 2041-1723
Éditeur: Nature Publishing Group
DOI: 10.1038/s41467-020-17680-w

RAD51D Aberrant Splicing in Breast Cancer: Identification of Splicing Regulatory Elements and Minigene-Based Evaluation of 53 DNA Variants

Auteurs: Elena Bueno-Martínez, Lara Sanoguera-Miralles, Alberto Valenzuela-Palomo, Víctor Lorca, Alicia Gómez-Sanz, Sara Carvalho, Jamie Allen, Mar Infante, Pedro Pérez-Segura, Conxi Lázaro, Douglas F. Easton, Peter Devilee, Maaike P. G. Vreeswijk, Miguel de la Hoya, Eladio A. Velasco
Publié dans: Cancers, Numéro 13/11, 2021, Page(s) 2845, ISSN 2072-6694
Éditeur: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers13112845

Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

Auteurs: Jingjing Liu, Wendy J. C. Prager - van der Smissen, J. Margriet Collée, Manjeet K. Bolla, Qin Wang, Kyriaki Michailidou, Joe Dennis, Thomas U. Ahearn, Kristiina Aittomäki, Christine B. Ambrosone, Irene L. Andrulis, Hoda Anton-Culver, Natalia N. Antonenkova, Volker Arndt, Norbert Arnold, Kristan J. Aronson, Annelie Augustinsson, Päivi Auvinen, Heiko Becher, Matthias W. Beckmann, Sabine Behre
Publié dans: Scientific Reports, Numéro 10/1, 2020, ISSN 2045-2322
Éditeur: Nature Publishing Group
DOI: 10.1038/s41598-020-65665-y

Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statement

Auteurs: Nora Pashayan, Antonis C. Antoniou, Urska Ivanus, Laura J. Esserman, Douglas F. Easton, David French, Gaby Sroczynski, Per Hall, Jack Cuzick, D. Gareth Evans, Jacques Simard, Montserrat Garcia-Closas, Rita Schmutzler, Odette Wegwarth, Paul Pharoah, Sowmiya Moorthie, Sandrine De Montgolfier, Camille Baron, Zdenko Herceg, Clare Turnbull, Corinne Balleyguier, Paolo Giorgi Rossi, Jelle Wesseling, Davi
Publié dans: Nature Reviews Clinical Oncology, Numéro 17/11, 2020, Page(s) 716-716, ISSN 1759-4774
Éditeur: Nature Publishing Group
DOI: 10.1038/s41571-020-0412-0

Prospective evaluation of a breast-cancer risk model integrating classical risk factors and polygenic risk in 15 cohorts from six countries

Auteurs: Amber N Hurson, Parichoy Pal Choudhury, Chi Gao, Anika Hüsing, Mikael Eriksson, Min Shi, Michael E Jones, D Gareth R Evans, Roger L Milne, Mia M Gaudet, Celine M Vachon, Daniel I Chasman, Douglas F Easton, Marjanka K Schmidt, Peter Kraft, Montserrat Garcia-Closas, Nilanjan Chatterjee, Christopher G Scott, Brian D Carter, Kara Martin, Elaine F Harkness, Mark N Brook, Thomas U Ahearn, Nasim Mavadda
Publié dans: International Journal of Epidemiology, 2021, ISSN 0300-5771
Éditeur: Oxford University Press
DOI: 10.1093/ije/dyab036

Characterisation of PALB2 tumours through whole-exome and whole-transcriptomic analyses

Auteurs: Pei Sze Ng, Jia Wern Pan, Muhammad Mamduh Ahmad Zabidi, Pathmanathan Rajadurai, Cheng Har Yip, Oscar M. Reuda, Alison M. Dunning, Antonis C. Antoniou, Douglas F. Easton, Carlos Caldas, Suet-Feung Chin, Soo Hwang Teo
Publié dans: npj Breast Cancer, Numéro 7/1, 2021, Page(s) 46, ISSN 2374-4677
Éditeur: Springer Nature
DOI: 10.1038/s41523-021-00254-4

Survey on Physicians’ Knowledge and Training Needs in Genetic Counseling in Germany

Auteurs: Julia Dick, Viktoria Aue, Simone Wesselmann, Anne Brédart, Sylvie Dolbeault, Peter Devilee, Dominique Stoppa-Lyonnet, Rita K. Schmutzler, Kerstin Rhiem
Publié dans: Breast Care, Numéro 16/4, 2021, Page(s) 389-395, ISSN 1661-3791
Éditeur: Karger AG
DOI: 10.1159/000511136

Breast cancer risk factors and their effects on survival: a Mendelian randomisation study

Auteurs: Maria Escala-Garcia, Anna Morra, Sander Canisius, Jenny Chang-Claude, Siddhartha Kar, Wei Zheng, Stig E. Bojesen, Doug Easton, Paul D. P. Pharoah, Marjanka K. Schmidt
Publié dans: BMC Medicine, Numéro 18/1, 2020, Page(s) 327, ISSN 1741-7015
Éditeur: BioMed Central
DOI: 10.1186/s12916-020-01797-2

Epidemiological and ES cell‐based functional evaluation of BRCA2 variants identified in families with breast cancer

Auteurs: Teresa Sullivan, Eswary Thirthagiri, Chan‐Eng Chong, Stacey Stauffer, Susan Reid, Eileen Southon, Tiara Hassan, Aravind Ravichandran, Eldarina Wijaya, Joanna Lim, Nur Aishah Mohd Taib, Farhana Fadzli, Cheng Har Yip, Mikael Hartman, Jingmei Li, Rob M. Dam, Susan L. North, Ranabir Das, Douglas F. Easton, Kajal Biswas, Soo‐Hwang Teo, Shyam K. Sharan
Publié dans: Human Mutation, Numéro 42/2, 2021, Page(s) 200-212, ISSN 1059-7794
Éditeur: John Wiley & Sons Inc.
DOI: 10.1002/humu.24154

Identification of 31 loci for mammographic density phenotypes and their associations with breast cancer risk

Auteurs: Weiva Sieh, Joseph H. Rothstein, Robert J. Klein, Stacey E. Alexeeff, Lori C. Sakoda, Eric Jorgenson, Russell B. McBride, Rebecca E. Graff, Valerie McGuire, Ninah Achacoso, Luana Acton, Rhea Y. Liang, Jafi A. Lipson, Daniel L. Rubin, Martin J. Yaffe, Douglas F. Easton, Catherine Schaefer, Neil Risch, Alice S. Whittemore, Laurel A. Habel
Publié dans: Nature Communications, Numéro 11/1, 2020, Page(s) 5116, ISSN 2041-1723
Éditeur: Nature Publishing Group
DOI: 10.1038/s41467-020-18883-x

Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status

Auteurs: Helian Feng, Alexander Gusev, Bogdan Pasaniuc, Lang Wu, Jirong Long, Zomoroda Abu‐full, Kristiina Aittomäki, Irene L. Andrulis, Hoda Anton‐Culver, Antonis C. Antoniou, Adalgeir Arason, Volker Arndt, Kristan J. Aronson, Banu K. Arun, Ella Asseryanis, Paul L. Auer, Jacopo Azzollini, Judith Balmaña, Rosa B. Barkardottir, Daniel R. Barnes, Daniel Barrowdale, Matthias W. Beckmann, Sabine Behrens,
Publié dans: Genetic Epidemiology, Numéro 44/5, 2020, Page(s) 442-468, ISSN 0741-0395
Éditeur: John Wiley & Sons Inc.
DOI: 10.1002/gepi.22288

Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?

Auteurs: JooYong Park, Ji-Yeob Choi, Jaesung Choi, Seokang Chung, Nan Song, Sue K. Park, Wonshik Han, Dong-Young Noh, Sei-Hyun Ahn, Jong Won Lee, Mi Kyung Kim, Sun Ha Jee, Wanqing Wen, Manjeet K. Bolla, Qin Wang, Joe Dennis, Kyriaki Michailidou, Mitul Shah, Don M. Conroy, Patricia A. Harrington, Rebecca Mayes, Kamila Czene, Per Hall, Lauren R. Teras, Alpa V. Patel, Fergus J. Couch, Janet E. Olson, Elinor J
Publié dans: Cancers, Numéro 13/10, 2021, Page(s) 2370, ISSN 2072-6694
Éditeur: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers13102370

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Auteurs: Juliette Coignard, Michael Lush, Jonathan Beesley, Tracy A. O’Mara, Joe Dennis, Jonathan P. Tyrer, Daniel R. Barnes, Lesley McGuffog, Goska Leslie, Manjeet K. Bolla, Muriel A. Adank, Simona Agata, Thomas Ahearn, Kristiina Aittomäki, Irene L. Andrulis, Hoda Anton-Culver, Volker Arndt, Norbert Arnold, Kristan J. Aronson, Banu K. Arun, Annelie Augustinsson, Jacopo Azzollini, Daniel Barrowdale, Car
Publié dans: Nature Communications, Numéro 12/1, 2021, Page(s) 1078, ISSN 2041-1723
Éditeur: Nature Publishing Group
DOI: 10.1038/s41467-020-20496-3

Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts

Auteurs: Daniele Giardiello, Michael Hauptmann, Ewout W. Steyerberg, Muriel A. Adank, Delal Akdeniz, Jannet C. Blom, Carl Blomqvist, Stig E. Bojesen, Manjeet K. Bolla, Mariël Brinkhuis, Jenny Chang-Claude, Kamila Czene, Peter Devilee, Alison M. Dunning, Douglas F. Easton, Diana M. Eccles, Peter A. Fasching, Jonine Figueroa, Henrik Flyger, Montserrat García-Closas, Lothar Haeberle, Christopher A. Haiman,
Publié dans: Breast Cancer Research and Treatment, Numéro 181/2, 2020, Page(s) 423-434, ISSN 0167-6806
Éditeur: Kluwer Academic Publishers
DOI: 10.1007/s10549-020-05611-8

Evaluating the role of alcohol consumption in breast and ovarian cancer susceptibility using population‐based cohort studies and two‐sample Mendelian randomization analyses

Auteurs: Jue‐Sheng Ong, Eske M. Derks, Mikael Eriksson, Jiyuan An, Liang‐Dar Hwang, Douglas F. Easton, Paul P. Pharoah, Andrew Berchuck, Linda E. Kelemen, Keitaro Matsuo, Georgia Chenevix‐Trench, Per Hall, Stig E. Bojesen, Penelope M. Webb, Stuart MacGregor
Publié dans: International Journal of Cancer, Numéro 148/6, 2021, Page(s) 1338-1350, ISSN 0020-7136
Éditeur: John Wiley & Sons Inc.
DOI: 10.1002/ijc.33308

Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects

Auteurs: Na Li, Magnus Zethoven, Simone McInerny, Lisa Devereux, Yu-Kuan Huang, Niko Thio, Dane Cheasley, Sara Gutiérrez-Enríquez, Alejandro Moles-Fernández, Orland Diez, Tu Nguyen-Dumont, Melissa C. Southey, John L. Hopper, Jacques Simard, Martine Dumont, Penny Soucy, Alfons Meindl, Rita Schmutzler, Marjanka K. Schmidt, Muriel A. Adank, Irene L. Andrulis, Eric Hahnen, Christoph Engel, Fabienne Lesueur,
Publié dans: npj Breast Cancer, Numéro 7/1, 2021, Page(s) 52, ISSN 2374-4677
Éditeur: Springer nature
DOI: 10.1038/s41523-021-00255-3

Use of the BOADICEA Web Application in clinical practice: appraisals by clinicians from various countries

Auteurs: Anne Brédart, Jean-Luc Kop, Antonis C. Antoniou, Alex P. Cunningham, Antoine De Pauw, Marc Tischkowitz, Hans Ehrencrona, Sylvie Dolbeault, Léonore Robieux, Kerstin Rhiem, Douglas F. Easton, Peter Devilee, Dominique Stoppa-Lyonnet, Rita Schmutlzer
Publié dans: Familial Cancer, 2017, ISSN 1389-9600
Éditeur: Kluwer Academic Publishers
DOI: 10.1007/s10689-017-0014-x

Clinicians’ use of breast cancer risk assessment tools according to their perceived importance of breast cancer risk factors: an international survey

Auteurs: Anne Brédart, Jean-Luc Kop, Antonis C. Antoniou, Alex P. Cunningham, Antoine De Pauw, Marc Tischkowitz, Hans Ehrencrona, Marjanka K. Schmidt, Sylvie Dolbeault, Kerstin Rhiem, Douglas F. Easton, Peter Devilee, Dominique Stoppa-Lyonnet, Rita Schmutlzer
Publié dans: Journal of Community Genetics, 2018, ISSN 1868-310X
Éditeur: Springer Verlag
DOI: 10.1007/s12687-018-0362-8

pedigreejs: a web-based graphical pedigree editor

Auteurs: Tim Carver, Alex P Cunningham, Chantal Babb de Villiers, Andrew Lee, Simon Hartley, Marc Tischkowitz, Fiona M Walter, Douglas F Easton, Antonis C Antoniou
Publié dans: Bioinformatics, Numéro 34/6, 2017, Page(s) 1069-1071, ISSN 1367-4803
Éditeur: Oxford University Press
DOI: 10.1093/bioinformatics/btx705

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

Auteurs: Roger L Milne, Karoline B Kuchenbaecker, Kyriaki Michailidou, Jonathan Beesley, Siddhartha Kar, Sara Lindström, Shirley Hui, Audrey Lemaçon, Penny Soucy, Joe Dennis, Xia Jiang, Asha Rostamianfar, Hilary Finucane, Manjeet K Bolla, Lesley McGuffog, Qin Wang, Cora M Aalfs, Marcia Adams, Julian Adlard, Simona Agata, Shahana Ahmed, Habibul Ahsan, Kristiina Aittomäki, Fares Al-Ejeh, Jamie Allen, Chri
Publié dans: Nature Genetics, Numéro 49/12, 2017, Page(s) 1767-1778, ISSN 1061-4036
Éditeur: Nature Publishing Group
DOI: 10.1038/ng.3785

Association analysis identifies 65 new breast cancer risk loci

Auteurs: Kyriaki Michailidou, Sara Lindström, Joe Dennis, Jonathan Beesley, Shirley Hui, Siddhartha Kar, Audrey Lemaçon, Penny Soucy, Dylan Glubb, Asha Rostamianfar, Manjeet K. Bolla, Qin Wang, Jonathan Tyrer, Ed Dicks, Andrew Lee, Zhaoming Wang, Jamie Allen, Renske Keeman, Ursula Eilber, Juliet D. French, Xiao Qing Chen, Laura Fachal, Karen McCue, Amy E. McCart Reed, Maya Ghoussaini, Jason S. Carroll, X
Publié dans: Nature, Numéro 551/7678, 2017, Page(s) 92-94, ISSN 0028-0836
Éditeur: Nature Publishing Group
DOI: 10.1038/nature24284

Patient-Centered Care in Breast Cancer Genetic Clinics

Auteurs: Anne Brédart, Amélie Anota, Julia Dick, Violetta Kuboth, Olivier Lareyre, Antoine De Pauw, Alejandra Cano, Dominique Stoppa-Lyonnet, Rita Schmutzler, Sylvie Dolbeault, Jean-Luc Kop
Publié dans: International Journal of Environmental Research and Public Health, Numéro 15/2, 2018, Page(s) 319, ISSN 1660-4601
Éditeur: MDPI
DOI: 10.3390/ijerph15020319

Inherited mutations in BRCA1 and BRCA2 in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia

Auteurs: Wei Xiong Wen, Jamie Allen, Kah Nyin Lai, Shivaani Mariapun, Siti Norhidayu Hasan, Pei Sze Ng, Daphne Shin-Chi Lee, Sheau Yee Lee, Sook-Yee Yoon, Joanna Lim, Shao Yan Lau, Brennan Decker, Karen Pooley, Leila Dorling, Craig Luccarini, Caroline Baynes, Don M Conroy, Patricia Harrington, Jacques Simard, Cheng Har Yip, Nur Aishah Mohd Taib, Weang Kee Ho, Antonis C Antoniou, Alison M Dunning, Douglas F
Publié dans: Journal of Medical Genetics, Numéro 55/2, 2018, Page(s) 97-103, ISSN 0022-2593
Éditeur: British Medical Association
DOI: 10.1136/jmedgenet-2017-104947

Shared heritability and functional enrichment across six solid cancers

Auteurs: Xia Jiang, Hilary K. Finucane, Fredrick R. Schumacher, Stephanie L. Schmit, Jonathan P. Tyrer, Younghun Han, Kyriaki Michailidou, Corina Lesseur, Karoline B. Kuchenbaecker, Joe Dennis, David V. Conti, Graham Casey, Mia M. Gaudet, Jeroen R. Huyghe, Demetrius Albanes, Melinda C. Aldrich, Angeline S. Andrew, Irene L. Andrulis, Hoda Anton-Culver, Antonis C. Antoniou, Natalia N. Antonenkova, Susanne M.
Publié dans: Nature Communications, Numéro 10/1, 2019, ISSN 2041-1723
Éditeur: Nature Publishing Group
DOI: 10.1038/s41467-018-08054-4

The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

Auteurs: Gisella Figlioli, Massimo Bogliolo, Irene Catucci, Laura Caleca, Sandra Viz Lasheras, Roser Pujol, Johanna I. Kiiski, Taru A. Muranen, Daniel R. Barnes, Joe Dennis, Kyriaki Michailidou, Manjeet K. Bolla, Goska Leslie, Cora M. Aalfs, Muriel A. Adank, Julian Adlard, Simona Agata, Karen Cadoo, Bjarni A. Agnarsson, Thomas Ahearn, Kristiina Aittomäki, Christine B. Ambrosone, Lesley Andrews, Hoda Anton
Publié dans: npj Breast Cancer, Numéro 5/1, 2019, ISSN 2374-4677
Éditeur: Springer Nature
DOI: 10.1038/s41523-019-0127-5

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

Auteurs: Mavaddat, N.; Michailidou, K.; Dennis, J.; Lush, M.; Fachal, L.; Lee, A.; Tyrer, J. P.; Chen, T-H; Wang, Q.; Bolla, M. K.; Yang, X.; Adank, M. A.; Ahearn, T.; Aittomäki, K.; Allen, J.; Andrulis, I. L.; Anton-Culver, H.; Antonenkova, N. N.; Arndt, V.; Aronson, K. J.; Auer, P. L.; Auvinen, P.; Barrdahl, M.; Beane Freeman, L. E.; Beckmann, M. W.; Behrens, S.; Benitez, J.; Bermisheva, M.; Bernstein,
Publié dans: American Journal of Human Genetics , 104 (1) pp. 21-34. (2019), Numéro 6, 2019, ISSN 0002-9297
Éditeur: University of Chicago Press

A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

Auteurs: Wu, L.; Shi, W.; Long, J.; Guo, X.; Michailidou, K.; Beesley, J.; Bolla, M. K.; Shu, X. O.; Lu, Y.; Cai, Q.; Al-Ejeh, F.; Rozali, E.; Wang, Q.; Dennis, J.; Li, B.; Zeng, C.; Feng, H.; Gusev, A.; Barfield, R. T.; Andrulis, I. L.; Anton-Culver, H.; Arndt, V.; Aronson, K. J.; Auer, P. L.; Barrdahl, M.; Baynes, C.; Beckmann, M. W.; Benitez, J.; Bermisheva, M.; Blomqvist, C.; Bogdanova, N. V.; Bojesen,
Publié dans: Nature Genetics , 50 pp. 968-978. (2018), Numéro 14, 2020, ISSN 1546-1718
Éditeur: Springer Nature

Two truncating variants in FANCC and breast cancer risk

Auteurs: Dörk, T.; Peterlongo, P.; Mannermaa, A.; Bolla, M. K.; Wang, Q.; Dennis, J.; Ahearn, T.; Andrulis, I. L.; Anton-Culver, H.; Arndt, V.; Aronson, K. J.; Augustinsson, A.; Freeman, L. E. B.; Beckmann, M. W.; Beeghly-Fadiel, A.; Behrens, S.; Bermisheva, M.; Blomqvist, C.; Bogdanova, N. V.; Bojesen, S. E.; Brauch, H.; Brenner, H.; Burwinkel, B.; Canzian, F.; Chan, T. L.; Chang-Claude, J.; Chanock, S.
Publié dans: Scientific Reports , 9 (1) , Article 12524. (2019), Numéro 14, 2019, ISSN 2045-2322
Éditeur: Nature Publishing Group

Functional analysis of genetic variants in the high-risk breast cancer susceptibility gene PALB2

Auteurs: Rick A. C. M. Boonen, Amélie Rodrigue, Chantal Stoepker, Wouter W. Wiegant, Bas Vroling, Milan Sharma, Magdalena B. Rother, Nandi Celosse, Maaike P. G. Vreeswijk, Fergus Couch, Jacques Simard, Peter Devilee, Jean-Yves Masson, Haico van Attikum
Publié dans: Nature Communications, Numéro 10/1, 2019, ISSN 2041-1723
Éditeur: Nature Publishing Group
DOI: 10.1038/s41467-019-13194-2

Prediction and clinical utility of a contralateral breast cancer risk model

Auteurs: Daniele Giardiello, Ewout W. Steyerberg, Michael Hauptmann, Muriel A. Adank, Delal Akdeniz, Carl Blomqvist, Stig E. Bojesen, Manjeet K. Bolla, Mariël Brinkhuis, Jenny Chang-Claude, Kamila Czene, Peter Devilee, Alison M. Dunning, Douglas F. Easton, Diana M. Eccles, Peter A. Fasching, Jonine Figueroa, Henrik Flyger, Montserrat García-Closas, Lothar Haeberle, Christopher A. Haiman, Per Hall, Ute Ha
Publié dans: Breast Cancer Research, Numéro 21/1, 2019, ISSN 1465-542X
Éditeur: Springer Nature
DOI: 10.1186/s13058-019-1221-1

Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium

Auteurs: Pooja Middha Kapoor, Sara Lindström, Sabine Behrens, Xiaoliang Wang, Kyriaki Michailidou, Manjeet K Bolla, Qin Wang, Joe Dennis, Alison M Dunning, Paul D P Pharoah, Marjanka K Schmidt, Peter Kraft, Montserrat García-Closas, Douglas F Easton, Roger L Milne, Jenny Chang-Claude
Publié dans: International Journal of Epidemiology, Numéro 49/1, 2019, Page(s) 216-232, ISSN 0300-5771
Éditeur: Oxford University Press
DOI: 10.1093/ije/dyz193

A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

Auteurs: Maria Escala-Garcia, Jean Abraham, Irene L. Andrulis, Hoda Anton-Culver, Volker Arndt, Alan Ashworth, Paul L. Auer, Päivi Auvinen, Matthias W. Beckmann, Jonathan Beesley, Sabine Behrens, Javier Benitez, Marina Bermisheva, Carl Blomqvist, William Blot, Natalia V. Bogdanova, Stig E. Bojesen, Manjeet K. Bolla, Anne-Lise Børresen-Dale, Hiltrud Brauch, Hermann Brenner, Sara Y. Brucker, Barbara Burwin
Publié dans: Nature Communications, Numéro 11/1, 2020, ISSN 2041-1723
Éditeur: Nature Publishing Group
DOI: 10.1038/s41467-019-14100-6

Genetic predisposition to mosaic Y chromosome loss in blood

Auteurs: Deborah J. Thompson, Giulio Genovese, Jonatan Halvardson, Jacob C. Ulirsch, Daniel J. Wright, Chikashi Terao, Olafur B. Davidsson, Felix R. Day, Patrick Sulem, Yunxuan Jiang, Marcus Danielsson, Hanna Davies, Joe Dennis, Malcolm G. Dunlop, Douglas F. Easton, Victoria A. Fisher, Florian Zink, Richard S. Houlston, Martin Ingelsson, Siddhartha Kar, Nicola D. Kerrison, Ben Kinnersley, Ragnar P. Kristja
Publié dans: Nature, Numéro 575/7784, 2019, Page(s) 652-657, ISSN 0028-0836
Éditeur: Nature Publishing Group
DOI: 10.1038/s41586-019-1765-3

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Auteurs: Laura Fachal, Hugues Aschard, Jonathan Beesley, Daniel R. Barnes, Jamie Allen, Siddhartha Kar, Karen A. Pooley, Joe Dennis, Kyriaki Michailidou, Constance Turman, Penny Soucy, Audrey Lemaçon, Michael Lush, Jonathan P. Tyrer, Maya Ghoussaini, Mahdi Moradi Marjaneh, Xia Jiang, Simona Agata, Kristiina Aittomäki, M. Rosario Alonso, Irene L. Andrulis, Hoda Anton-Culver, Natalia N. Antonenkova, Adalge
Publié dans: Nature Genetics, Numéro 52/1, 2020, Page(s) 56-73, ISSN 1061-4036
Éditeur: Nature Publishing Group
DOI: 10.1038/s41588-019-0537-1

Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk

Auteurs: Celine M. Vachon, Christopher G. Scott, Rulla M. Tamimi, Deborah J. Thompson, Peter A. Fasching, Jennifer Stone, Melissa C. Southey, Stacey Winham, Sara Lindström, Jenna Lilyquist, Graham G. Giles, Roger L. Milne, Robert J. MacInnis, Laura Baglietto, Jingmei Li, Kamila Czene, Manjeet K. Bolla, Qin Wang, Joe Dennis, Lothar Haeberle, Mikael Eriksson, Peter Kraft, Robert Luben, Nick Wareham, Janet E
Publié dans: Breast Cancer Research, Numéro 21/1, 2019, ISSN 1465-542X
Éditeur: Springer Nature
DOI: 10.1186/s13058-019-1138-8

The functional ALDH2 polymorphism is associated with breast cancer risk: A pooled analysis from the Breast Cancer Association Consortium

Auteurs: Tomotaka Ugai, Roger L. Milne, Hidemi Ito, Kristan J. Aronson, Manjeet K. Bolla, Tsun Chan, Ching W. Chan, Ji-Yeob Choi, Don M. Conroy, Joe Dennis, Alison M. Dunning, Douglas F. Easton, Valerie Gaborieau, Anna Gonzalez-Neira, Mikael Hartman, Catherine S. Healey, Motoki Iwasaki, Esther M. John, Daehee Kang, Sung-Won Kim, Ava Kwong, Artitaya Lophatananon, Kyriaki Michailidou, Nur Aishah Mohd Taib, K
Publié dans: Molecular Genetics & Genomic Medicine, Numéro 7/6, 2019, Page(s) e707, ISSN 2324-9269
Éditeur: John Wiley & Sons
DOI: 10.1002/mgg3.707

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

Auteurs: Manuel A. Ferreira, Eric R. Gamazon, Fares Al-Ejeh, Kristiina Aittomäki, Irene L. Andrulis, Hoda Anton-Culver, Adalgeir Arason, Volker Arndt, Kristan J. Aronson, Banu K. Arun, Ella Asseryanis, Jacopo Azzollini, Judith Balmaña, Daniel R. Barnes, Daniel Barrowdale, Matthias W. Beckmann, Sabine Behrens, Javier Benitez, Marina Bermisheva, Katarzyna Białkowska, Carl Blomqvist, Natalia V. Bogdanova,
Publié dans: Nature Communications, Numéro 10/1, 2019, ISSN 2041-1723
Éditeur: Nature Publishing Group
DOI: 10.1038/s41467-018-08053-5

Genome-wide association study of germline variants and breast cancer-specific mortality

Auteurs: Maria Escala-Garcia, Qi Guo, Thilo Dörk, Sander Canisius, Renske Keeman, Joe Dennis, Jonathan Beesley, Julie Lecarpentier, Manjeet K. Bolla, Qin Wang, Jean Abraham, Irene L. Andrulis, Hoda Anton-Culver, Volker Arndt, Paul L. Auer, Matthias W. Beckmann, Sabine Behrens, Javier Benitez, Marina Bermisheva, Leslie Bernstein, Carl Blomqvist, Bram Boeckx, Stig E. Bojesen, Bernardo Bonanni, Anne-Lise Bø
Publié dans: British Journal of Cancer, Numéro 120/6, 2019, Page(s) 647-657, ISSN 0007-0920
Éditeur: Nature Publishing Group
DOI: 10.1038/s41416-019-0393-x

Genetically Predicted Levels of DNA Methylation Biomarkers and Breast Cancer Risk: Data From 228 951 Women of European Descent

Auteurs: Yaohua Yang, Lang Wu, Xiao-Ou Shu, Qiuyin Cai, Xiang Shu, Bingshan Li, Xingyi Guo, Fei Ye, Kyriaki Michailidou, Manjeet K Bolla, Qin Wang, Joe Dennis, Irene L Andrulis, Hermann Brenner, Georgia Chenevix-Trench, Daniele Campa, Jose E Castelao, Manuela Gago-Dominguez, Thilo Dörk, Antoinette Hollestelle, Artitaya Lophatananon, Kenneth Muir, Susan L Neuhausen, Håkan Olsson, Dale P Sandler, Jacques S
Publié dans: JNCI: Journal of the National Cancer Institute, Numéro 112/3, 2019, Page(s) 295-304, ISSN 0027-8874
Éditeur: Oxford University Press
DOI: 10.1093/jnci/djz109

Targeted RNA-seq successfully identifies normal and pathogenic splicing events in breast/ovarian cancer susceptibility and Lynch syndrome genes

Auteurs: Rita D. Brandão, Klaas Mensaert, Irene López-Perolio, Demis Tserpelis, Markos Xenakis, Vanessa Lattimore, Logan C. Walker, Anders Kvist, Ana Vega, Sara Gutiérrez-Enríquez, Orland Díez, Miguel de la Hoya, Amanda B. Spurdle, Tim De Meyer, Marinus J. Blok
Publié dans: International Journal of Cancer, Numéro 145/2, 2019, Page(s) 401-414, ISSN 0020-7136
Éditeur: John Wiley & Sons Inc.
DOI: 10.1002/ijc.32114

Alternative splicing and ACMG-AMP-2015-based classification of PALB2 genetic variants: an ENIGMA report

Auteurs: Irene Lopez-Perolio, Raphaël Leman, Raquel Behar, Vanessa Lattimore, John F Pearson, Laurent Castéra, Alexandra Martins, Dominique Vaur, Nicolas Goardon, Grégoire Davy, Pilar Garre, Vanesa García-Barberán, Patricia Llovet, Pedro Pérez-Segura, Eduardo Díaz-Rubio, Trinidad Caldés, Kathleen S Hruska, Vickie Hsuan, Sitao Wu, Tina Pesaran, Rachid Karam, Johan Vallon-Christersson, Ake Borg, kCon
Publié dans: Journal of Medical Genetics, Numéro 56/7, 2019, Page(s) 453-460, ISSN 0022-2593
Éditeur: British Medical Association
DOI: 10.1136/jmedgenet-2018-105834

Comprehensive Assessment of BARD1 Messenger Ribonucleic Acid Splicing With Implications for Variant Classification

Auteurs: Logan C. Walker, Vanessa Lilian Lattimore, Anders Kvist, Petra Kleiblova, Petra Zemankova, Lucy de Jong, George A. R. Wiggins, Christopher Hakkaart, Simone L. Cree, Raquel Behar, Claude Houdayer, kConFab Investigators, Michael T. Parsons, Martin A. Kennedy, Amanda B. Spurdle, Miguel de la Hoya
Publié dans: Frontiers in Genetics, Numéro 10, 2019, ISSN 1664-8021
Éditeur: Frontiers Media
DOI: 10.3389/fgene.2019.01139

Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

Auteurs: Michael T. Parsons, Emma Tudini, Hongyan Li, Eric Hahnen, Barbara Wappenschmidt, Lidia Feliubadaló, Cora M. Aalfs, Simona Agata, Kristiina Aittomäki, Elisa Alducci, María Concepción Alonso‐Cerezo, Norbert Arnold, Bernd Auber, Rachel Austin, Jacopo Azzollini, Judith Balmaña, Elena Barbieri, Claus R. Bartram, Ana Blanco, Britta Blümcke, Sandra Bonache, Bernardo Bonanni, Åke Borg, Beatrice B
Publié dans: Human Mutation, Numéro 40/9, 2019, Page(s) 1557-1578, ISSN 1059-7794
Éditeur: John Wiley & Sons Inc.
DOI: 10.1002/humu.23818

Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods study

Auteurs: Stephanie Archer, Chantal Babb de Villiers, Fiona Scheibl, Tim Carver, Simon Hartley, Andrew Lee, Alex P. Cunningham, Douglas F. Easton, Jennifer G. McIntosh, Jon Emery, Marc Tischkowitz, Antonis C. Antoniou, Fiona M. Walter
Publié dans: PLOS ONE, Numéro 15/3, 2020, Page(s) e0229999, ISSN 1932-6203
Éditeur: Public Library of Science
DOI: 10.1371/journal.pone.0229999

BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors

Auteurs: Andrew Lee, Nasim Mavaddat, Amber N. Wilcox, Alex P. Cunningham, Tim Carver, Simon Hartley, Chantal Babb de Villiers, Angel Izquierdo, Jacques Simard, Marjanka K. Schmidt, Fiona M. Walter, Nilanjan Chatterjee, Montserrat Garcia-Closas, Marc Tischkowitz, Paul Pharoah, Douglas F. Easton, Antonis C. Antoniou
Publié dans: Genetics in Medicine, Numéro 21/8, 2019, Page(s) 1708-1718, ISSN 1098-3600
Éditeur: Lippincott Williams & Wilkins Ltd.
DOI: 10.1038/s41436-018-0406-9

Thorough in silico and in vitro cDNA analysis of 21 putative BRCA1 and BRCA2 splice variants and a complex tandem duplication in BRCA2 allowing the identification of activated cryptic splice donor sites in BRCA2 exon 11

Auteurs: Annelot Baert, Eva Machackova, Ilse Coene, Carol Cremin, Kristin Turner, Cheryl Portigal-Todd, Marie Jill Asrat, Jennifer Nuk, Allison Mindlin, Sean Young, Andree MacMillan, Tom Van Maerken, Martin Trbusek, Wendy McKinnon, Marie E. Wood, William D. Foulkes, Marta Santamariña, Miguel de la Hoya, Lenka Foretova, Bruce Poppe, Anne Vral, Toon Rosseel, Kim De Leeneer, Ana Vega, Kathleen B. M. Claes
Publié dans: Human Mutation, Numéro 39/4, 2018, Page(s) 515-526, ISSN 1059-7794
Éditeur: John Wiley & Sons Inc.
DOI: 10.1002/humu.23390

Common Pitfalls and Novel Opportunities for Predicting Variant Pathogenicity

Auteurs: Tom van den Bergh, Bas Vroling
Publié dans: Biochemistry & Physiology: Open Access, Numéro 01/05, 2016, ISSN 2168-9652
Éditeur: OMICS Publishing Group
DOI: 10.4172/2168-9652.1000197

The Spectrum of FANCM Protein Truncating Variants in European Breast Cancer Cases

Auteurs: Gisella Figlioli, Anders Kvist, Emma Tham, Jana Soukupova, Petra Kleiblova, Taru Muranen, Nadine Andrieu, Jacopo Azzollini, Judith Balmaña, Alicia Barroso, Javier Benítez, Birgitte Bertelsen, Ana Blanco, Bernardo Bonanni, Åke Borg, Joan Brunet, Daniele Calistri, Mariarosaria Calvello, Stepan Chvojka, Laura Cortesi, Esther Darder, Jesús Del Valle, Orland Diez, ENIGMA Consortium, Séverine Eon-M
Publié dans: Cancers, Numéro 12/2, 2020, Page(s) 292, ISSN 2072-6694
Éditeur: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers12020292

PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1

Auteurs: Xiang Jiao, Christos Aravidis, Rajeshwari Marikkannu, Johanna Rantala, Simone Picelli, Tatjana Adamovic, Tao Liu, Paula Maguire, Barbara Kremeyer, Liping Luo, Susanna von Holst, Vinaykumar Kontham, Jessada Thutkawkorapin, Sara Margolin, Quan Du, Johanna Lundin, Kyriaki Michailidou, Manjeet K. Bolla, Qin Wang, Joe Dennis, Michael Lush, Christine B. Ambrosone, Irene L. Andrulis, Hoda Anton-Culver, N
Publié dans: Oncotarget, Numéro 8/61, 2017, ISSN 1949-2553
Éditeur: Impact Journals
DOI: 10.18632/oncotarget.21800

Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium

Auteurs: Myrto Barrdahl, Anja Rudolph, John L. Hopper, Melissa C. Southey, Annegien Broeks, Peter A. Fasching, Matthias W. Beckmann, Manuela Gago-Dominguez, J. Esteban Castelao, Pascal Guénel, Thérèse Truong, Stig E. Bojesen, Susan M. Gapstur, Mia M. Gaudet, Hermann Brenner, Volker Arndt, Hiltrud Brauch, Ute Hamann, Arto Mannermaa, Diether Lambrechts, Lynn Jongen, Dieter Flesch-Janys, Kathrin Thoene, Fe
Publié dans: International Journal of Cancer, Numéro 141/9, 2017, Page(s) 1830-1840, ISSN 0020-7136
Éditeur: John Wiley & Sons Inc.
DOI: 10.1002/ijc.30859

RECQL5 : Another DNA helicase potentially involved in hereditary breast cancer susceptibility

Auteurs: Alejandra Tavera-Tapia, Miguel de la Hoya, Oriol Calvete, Paloma Martin-Gimeno, Victoria Fernández, José Antonio Macías, Beatriz Alonso, Luz Pombo, Carles de Diego, Rosario Alonso, Guillermo Pita, Alicia Barroso, Miguel Urioste, Trinidad Caldés, Joseph A. Newman, Javier Benítez, Ana Osorio
Publié dans: Human Mutation, Numéro 40/5, 2019, Page(s) 566-577, ISSN 1059-7794
Éditeur: John Wiley & Sons Inc.
DOI: 10.1002/humu.23732

Psychosocial problems in women attending French, German and Spanish genetics clinics before and after targeted or multigene testing results: an observational prospective study

Auteurs: Anne Brédart, Jean-Luc Kop, Julia Dick, Alejandra Cano, Antoine De Pauw, Amélie Anota, Joan Brunet, Peter Devilee, Dominique Stoppa-Lyonnet, Rita Schmutzler, Sylvie Dolbeault
Publié dans: BMJ Open, Numéro 9/9, 2019, Page(s) e029926, ISSN 2044-6055
Éditeur: BMJ Publishing Group
DOI: 10.1136/bmjopen-2019-029926

How to facilitate psychosocial adjustment in women tested for hereditary breast or ovarian cancer susceptibility? Insights from network analysis

Auteurs: Anne Brédart, Julia Dick, Alejandra Cano, Léonore Robieux, Antoine De Pauw, Rita Schmutzler, Dominique Stoppa‐Lyonnet, Sylvie Dolbeault, Jean‐Luc Kop
Publié dans: Psycho-Oncology, Numéro 29/3, 2019, Page(s) 550-556, ISSN 1057-9249
Éditeur: John Wiley & Sons Inc.
DOI: 10.1002/pon.5302

The “Psychosocial Aspects in Hereditary Cancer” questionnaire in women attending breast cancer genetic clinics: Psychometric validation across French‐, German‐ and Spanish‐language versions

Auteurs: Anne Brédart, Amélie Anota, Julia Dick, Alejandra Cano, Antoine De Pauw, Jean‐Luc Kop, Neil K. Aaronson, Eveline M. Bleiker, Joan Brunet, Peter Devilee, Dominique Stoppa‐Lyonnet, Rita Schmutzler, Sylvie Dolbeault
Publié dans: European Journal of Cancer Care, Numéro 29/1, 2019, ISSN 0961-5423
Éditeur: Blackwell Publishing Inc.
DOI: 10.1111/ecc.13173

Making sense of big data in health research: Towards an EU action plan

Auteurs: Charles Auffray, Rudi Balling, Inês Barroso, László Bencze, Mikael Benson, Jay Bergeron, Enrique Bernal-Delgado, Niklas Blomberg, Christoph Bock, Ana Conesa, Susanna Del Signore, Christophe Delogne, Peter Devilee, Alberto Di Meglio, Marinus Eijkemans, Paul Flicek, Norbert Graf, Vera Grimm, Henk-Jan Guchelaar, Yi-Ke Guo, Ivo Glynne Gut, Allan Hanbury, Shahid Hanif, Ralf-Dieter Hilgers, Ángel Ho
Publié dans: Genome Medicine, Numéro 8/1, 2016, ISSN 1756-994X
Éditeur: BioMed Central
DOI: 10.1186/s13073-016-0323-y

E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium

Auteurs: Hisani N. Horne, Hannah Oh, Mark E. Sherman, Maya Palakal, Stephen M. Hewitt, Marjanka K. Schmidt, Roger L. Milne, David Hardisson, Javier Benitez, Carl Blomqvist, Manjeet K. Bolla, Hermann Brenner, Jenny Chang-Claude, Renata Cora, Fergus J. Couch, Katarina Cuk, Peter Devilee, Douglas F. Easton, Diana M. Eccles, Ursula Eilber, Jaana M. Hartikainen, Päivi Heikkilä, Bernd Holleczek, Maartje J. Hoo
Publié dans: Scientific Reports, Numéro 8/1, 2018, ISSN 2045-2322
Éditeur: Nature Publishing Group
DOI: 10.1038/s41598-018-23733-4

rs2735383, located at a microRNA binding site in the 3’UTR of NBS1, is not associated with breast cancer risk

Auteurs: Jingjing Liu, Ivona Lončar, J. Margriet Collée, Manjeet K. Bolla, Joe Dennis, Kyriaki Michailidou, Qin Wang, Irene L. Andrulis, Monica Barile, Matthias W. Beckmann, Sabine Behrens, Javier Benitez, Carl Blomqvist, Bram Boeckx, Natalia V. Bogdanova, Stig E. Bojesen, Hiltrud Brauch, Paul Brennan, Hermann Brenner, Annegien Broeks, Barbara Burwinkel, Jenny Chang-Claude, Shou-Tung Chen, Georgia Chenev
Publié dans: Scientific Reports, Numéro 6/1, 2016, ISSN 2045-2322
Éditeur: Nature Publishing Group
DOI: 10.1038/srep36874

Whole exome sequencing identifies PLEC , EXO5 and DNAH7 as novel susceptibility genes in testicular cancer

Auteurs: Beatriz Paumard-Hernández, Oriol Calvete, Lucia Inglada Pérez, Héctor Tejero, Fátima Al-Shahrour, Guillermo Pita, Alicia Barroso, Juan Carlos Triviño, Miguel Urioste, Claudia Valverde, Enrique González Billalabeitia, Vanesa Quiroga, Juan Francisco Rodríguez Moreno, Antonio Fernández Aramburo, Cristina López, Pablo Maroto, Javier Sastre, María José Juan Fita, Ignacio Duran, Isabel Lorenz
Publié dans: International Journal of Cancer, Numéro 143/8, 2018, Page(s) 1954-1962, ISSN 0020-7136
Éditeur: John Wiley & Sons Inc.
DOI: 10.1002/ijc.31604

DNA damage and hormone-related cancer: a repair pathway view

Auteurs: Karen A Pooley, Alison M Dunning
Publié dans: Human Molecular Genetics, Numéro 28/R2, 2019, Page(s) R180-R186, ISSN 0964-6906
Éditeur: Oxford University Press
DOI: 10.1093/hmg/ddz206

Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium

Auteurs: Anja Rudolph, Minsun Song, Mark N Brook, Roger L Milne, Nasim Mavaddat, Kyriaki Michailidou, Manjeet K Bolla, Qin Wang, Joe Dennis, Amber N Wilcox, John L Hopper, Melissa C Southey, Renske Keeman, Peter A Fasching, Matthias W Beckmann, Manuela Gago-Dominguez, Jose E Castelao, Pascal Guénel, Thérèse Truong, Stig E Bojesen, Henrik Flyger, Hermann Brenner, Volker Arndt, Hiltrud Brauch, Thomas Brü
Publié dans: International Journal of Epidemiology, Numéro 47/2, 2018, Page(s) 526-536, ISSN 0300-5771
Éditeur: Oxford University Press
DOI: 10.1093/ije/dyx242

Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis

Auteurs: Xiang Shu, Lang Wu, Nikhil K Khankari, Xiao-Ou Shu, Thomas J Wang, Kyriaki Michailidou, Manjeet K Bolla, Qin Wang, Joe Dennis, Roger L Milne, Marjanka K Schmidt, Paul D P Pharoah, Irene L Andrulis, David J Hunter, Jacques Simard, Douglas F Easton, Wei Zheng, Beeghly-Fadiel J Alicia, Hoda Anton-Culver, Natalia N Antonenkova, Volker Arndt, Kristan J Aronson, Paul L Auer, Myrto Barrdahl, Caroline Bay
Publié dans: International Journal of Epidemiology, Numéro 48/3, 2018, Page(s) 795-806, ISSN 0300-5771
Éditeur: Oxford University Press
DOI: 10.1093/ije/dyy201

Towards controlled terminology for reporting germline cancer susceptibility variants: an ENIGMA report

Auteurs: Amanda B Spurdle, Stephanie Greville-Heygate, Antonis C Antoniou, Melissa Brown, Leslie Burke, Miguel de la Hoya, Susan Domchek, Thilo Dörk, Helen V Firth, Alvaro N Monteiro, Arjen Mensenkamp, Michael T Parsons, Paolo Radice, Mark Robson, Marc Tischkowitz, Emma Tudini, Clare Turnbull, Maaike PG Vreeswijk, Logan C Walker, Sean Tavtigian, Diana M Eccles
Publié dans: Journal of Medical Genetics, Numéro 56/6, 2019, Page(s) 347-357, ISSN 0022-2593
Éditeur: British Medical Association
DOI: 10.1136/jmedgenet-2018-105872

A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

Auteurs: Lang Wu, Wei Shi, Jirong Long, Xingyi Guo, Kyriaki Michailidou, Jonathan Beesley, Manjeet K. Bolla, Xiao-Ou Shu, Yingchang Lu, Qiuyin Cai, Fares Al-Ejeh, Esdy Rozali, Qin Wang, Joe Dennis, Bingshan Li, Chenjie Zeng, Helian Feng, Alexander Gusev, Richard T. Barfield, Irene L. Andrulis, Hoda Anton-Culver, Volker Arndt, Kristan J. Aronson, Paul L. Auer, Myrto Barrdahl, Caroline Baynes, Matthias W. Be
Publié dans: Nature Genetics, Numéro 50/7, 2018, Page(s) 968-978, ISSN 1061-4036
Éditeur: Nature Publishing Group
DOI: 10.1038/s41588-018-0132-x

Almost 2% of Spanish breast cancer families are associated to germline pathogenic mutations in the ATM gene

Auteurs: A. Tavera-Tapia, L. Pérez-Cabornero, J. A. Macías, M. I. Ceballos, G. Roncador, M. de la Hoya, A. Barroso, V. Felipe-Ponce, R. Serrano-Blanch, C. Hinojo, M. D. Miramar-Gallart, M. Urioste, T. Caldés, S. Santillan-Garzón, J. Benitez, A. Osorio
Publié dans: Breast Cancer Research and Treatment, Numéro 161/3, 2017, Page(s) 597-604, ISSN 0167-6806
Éditeur: Kluwer Academic Publishers
DOI: 10.1007/s10549-016-4058-7

Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

Auteurs: Haoyu Zhang, Thomas U. Ahearn, Julie Lecarpentier, Daniel Barnes, Jonathan Beesley, Guanghao Qi, Xia Jiang, Tracy A. O’Mara, Ni Zhao, Manjeet K. Bolla, Alison M. Dunning, Joe Dennis, Qin Wang, Zumuruda Abu Ful, Kristiina Aittomäki, Irene L. Andrulis, Hoda Anton-Culver, Volker Arndt, Kristan J. Aronson, Banu K. Arun, Paul L. Auer, Jacopo Azzollini, Daniel Barrowdale, Heiko Becher, Matthias W. Be
Publié dans: Nature Genetics, Numéro 52/6, 2020, Page(s) 572-581, ISSN 1061-4036
Éditeur: Nature Publishing Group
DOI: 10.1038/s41588-020-0609-2

Comprehensive Functional Characterization and Clinical Interpretation of 20 Splice-Site Variants of the RAD51C Gene

Auteurs: Lara Sanoguera-Miralles, Alberto Valenzuela-Palomo, Elena Bueno-Martínez, Patricia Llovet, Beatriz Díez-Gómez, María José Caloca, Pedro Pérez-Segura, Eugenia Fraile-Bethencourt, Marta Colmena, Sara Carvalho, Jamie Allen, Douglas F. Easton, Peter Devilee, Maaike P. G. Vreeswijk, Miguel de la Hoya, Eladio A. Velasco
Publié dans: Cancers, Numéro 12/12, 2020, Page(s) 3771, ISSN 2072-6694
Éditeur: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers12123771

Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment

Auteurs: Anna Morra, Maria Escala-Garcia, Jonathan Beesley, Renske Keeman, Sander Canisius, Thomas U. Ahearn, Irene L. Andrulis, Hoda Anton-Culver, Volker Arndt, Paul L. Auer, Annelie Augustinsson, Laura E. Beane Freeman, Heiko Becher, Matthias W. Beckmann, Sabine Behrens, Stig E. Bojesen, Manjeet K. Bolla, Hermann Brenner, Thomas Brüning, Saundra S. Buys, Bette Caan, Daniele Campa, Federico Canzian, Jose
Publié dans: Breast Cancer Research, Numéro 23/1, 2021, Page(s) 86, ISSN 1465-542X
Éditeur: Springer Nature
DOI: 10.1186/s13058-021-01450-7

Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium

Auteurs: Anna Morra, Audrey Y. Jung, Sabine Behrens, Renske Keeman, Thomas U. Ahearn, Hoda Anton-Culver, Volker Arndt, Annelie Augustinsson, Päivi K. Auvinen, Laura E. Beane Freeman, Heiko Becher, Matthias W. Beckmann, Carl Blomqvist, Stig E. Bojesen, Manjeet K. Bolla, Hermann Brenner, Ignacio Briceno, Sara Y. Brucker, Nicola J. Camp, Daniele Campa, Federico Canzian, Jose E. Castelao, Stephen J. Chanock,
Publié dans: Cancer Epidemiology Biomarkers & Prevention, Numéro 30/4, 2021, Page(s) 623-642, ISSN 1055-9965
Éditeur: American Association for Cancer Research
DOI: 10.1158/1055-9965.epi-20-0924

Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Auteurs: Juliette Coignard, Michael Lush, Jonathan Beesley, Tracy A. O’Mara, Joe Dennis, Jonathan P. Tyrer, Daniel R. Barnes, Lesley McGuffog, Goska Leslie, Manjeet K. Bolla, Muriel A. Adank, Simona Agata, Thomas Ahearn, Kristiina Aittomäki, Irene L. Andrulis, Hoda Anton-Culver, Volker Arndt, Norbert Arnold, Kristan J. Aronson, Banu K. Arun, Annelie Augustinsson, Jacopo Azzollini, Daniel Barrowdale, Car
Publié dans: Nature Communications, Numéro 12/1, 2021, Page(s) 2986, ISSN 2041-1723
Éditeur: Nature Publishing Group
DOI: 10.1038/s41467-021-23162-4

Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women

Auteurs: Babatunde Adedokun, Zhaohui Du, Guimin Gao, Thomas U. Ahearn, Kathryn L. Lunetta, Gary Zirpoli, Jonine Figueroa, Esther M. John, Leslie Bernstein, Wei Zheng, Jennifer J. Hu, Regina G. Ziegler, Sarah Nyante, Elisa V. Bandera, Sue A. Ingles, Michael F. Press, Sandra L. Deming-Halverson, Jorge L. Rodriguez-Gil, Song Yao, Temidayo O. Ogundiran, Oladosu Ojengbede, William Blot, Melissa A. Troester, Kat
Publié dans: Nature Communications, Numéro 12/1, 2021, Page(s) 4198, ISSN 2041-1723
Éditeur: Nature Publishing Group
DOI: 10.1038/s41467-021-24327-x

Information needs on breast cancer genetic and non-genetic risk factors in relatives of women with a BRCA1/2 or PALB2 pathogenic variant

Auteurs: Anne Brédart, Antoine De Pauw, Amélie Anota, Anja Tüchler, Julia Dick, Anita Müller, Jean-Luc Kop, Kerstin Rhiem, Rita Schmutzler, Peter Devilee, Dominique Stoppa-Lyonnet, Sylvie Dolbeault
Publié dans: The Breast, Numéro 60, 2021, Page(s) 38-44, ISSN 0960-9776
Éditeur: Churchill Livingstone
DOI: 10.1016/j.breast.2021.08.011

Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women

Auteurs: Leila Dorling, Sara Carvalho, Jamie Allen, Anna González-Neira, Craig Luccarini, Cecilia Wahlström, Karen A. Pooley, Michael T. Parsons, Cristina Fortuno, Qin Wang, Manjeet K. Bolla, Joe Dennis, Renske Keeman, M. Rosario Alonso, Nuria Álvarez, Belen Herraez, Victoria Fernandez, Rocio Núñez-Torres, Ana Osorio, Jeanette Valcich, Minerva Li, Therese Törngren, Patricia A. Harrington, Caroline Ba
Publié dans: New England Journal of Medicine, Numéro 384/5, 2021, Page(s) 428-439, ISSN 0028-4793
Éditeur: Massachusetts Medical Society
DOI: 10.1056/nejmoa1913948

Assessing breast cancer risk

Auteurs: Peter Devilee
Publié dans: 2018
Éditeur: Impact

Recherche de données OpenAIRE...

Livrables

Publications

Partager cette page

Télécharger